Alzheimer's Disease Clinical Trials in New York

Showing 221-240 of 291 trials

Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training

NCT00120874

The purpose of this study is to determine whether a comprehensive, individualized management approach with caregiver training and medication with memantine will alleviate symptoms in community dwelling patients with moderate to severe Alzheimer's disease.

Alzheimer's Disease

NYU Langone Health20 participantsStarted Aug 2006

New York, New York, United States

TERMINATEDPhase 2< 1 mile

A Long Term Extension Study Evaluating ACC-001 With QS-21 in Subjects With Mild to Moderate Alzheimer's Disease

NCT00960531

The purpose of this study is to assess the long term safety, tolerability, and immunogenicity of ACC-001, an investigational vaccine, plus QS-21 in subjects with mild to moderate Alzheimer's disease.

Alzheimer Disease

Pfizer160 participantsStarted Jul 2009

Phoenix, Arizona, United States • Sun City, Arizona, United States • Sun City, Arizona, United States +25 more locations

Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training

A Long Term Extension Study Evaluating ACC-001 With QS-21 in Subjects With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease Trials in Other Cities

Effect of NeuroAD on the Cognitive Function of Alzheimer Patients

Study Evaluating ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease

Memantine Plus Es-citalopram in Elderly Depressed Patients With Cognitive Impairment

DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease

Home-Based Assessment for Alzheimer Disease Prevention

ADNI: Alzheimer's Disease Neuroimaging Initiative

Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025

Development of NIC5-15 in the Treatment of Alzheimer's Disease

A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease

Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

Phase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared to Histopathology

Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's Disease

Study to Evaluate the Effects of Food Ingestion on the Pharmacokinetics of CHF 5074 in Healthy Young Male Subjects

Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and Controls

Development of Therapeutic Intervention for Sleep in Alzheimer/Caregiver Dyads

Partners in Dementia Care: A Telephone Care Consultation Intervention Provided to Veterans in Partnership With Local Alzheimer's Association Chapters

Efficacy Study of a ZT-1 Implant in Patients Suffering From Alzheimer's Disease

QTc Study of Rosi XR in Healthy Volunteers

Other Conditions in New York